AA
ZOM

Ancora Advisors’s Zomedica Corp. ZOM Stock Holding History

Ancora Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.35K Hold
83,610
– – ﹤0.01% 1524
2026
Q1 		$9.98K Sell
83,610
-216,390
-72% -$25.8K ﹤0.01% 1774
2025
Q4 		$30.5K Sell
300,000
-520,418
-63% -$53K ﹤0.01% 1342
2025
Q3 		$64.7K Sell
820,418
-3,822,917
-82% -$302K ﹤0.01% 974
2025
Q2 		$188K Sell
4,643,335
-76,786
-2% -$3.11K ﹤0.01% 736
2025
Q1 		$274K Buy
+4,720,121
New +$578K 0.01% 651

Other funds holding ZOM

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GCP
Gill Capital Partners Denver, Colorado $378M AUM 18.32% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Ancora Advisors's ZOM Position: Q2 2026 in Review

Ancora Advisors held its Zomedica Corp. (ZOM) position steady in Q2 2026 at 83,610 shares worth $8.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Ancora Advisors first reported a position in ZOM in Q1 2025 and has held it in 6 quarters since. The position peaked at $274K in Q1 2025. 7 funds tracked by Wall St. Rank hold ZOM as of Q2 2026.

  • Ancora Advisors held 83,610 shares of Zomedica Corp. worth $8.35K as of Q2 2026.
  • Ancora Advisors left its Zomedica Corp. share count unchanged in Q2 2026.
  • Zomedica Corp. made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1524 holding.
  • Ancora Advisors first reported a position in Zomedica Corp. in Q1 2025 and has held it in 6 quarters since.
  • Ancora Advisors's Zomedica Corp. position peaked at $274K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.